About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02797691

Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans

CBT for common mental disorders has a strong evidence base in both the USA and the UK. There are wider cultural and linguistic differences between Non Pashtun and Pashtun population of Pakistan and Af...

Lead sponsor: Peshawar Medical College•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Peshawar Medical College

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All those who fulfill the diagnostic criteria of Depressive episode (F32) or Recurrent depressive disorder (F33 except 33.4) or Anxiety disorder using ICD10 RDC and who live within travelling distance of the psychiatry department in Peshawar will be approached. Those patients, who have agreed to enter the study, will be assessed 2 weeks later, to fill in the baseline measures when they attend their first appointment. Patients will be asked to attend a further appointment at the end of study period and will be assessed again.

Exclusion Criteria

•Excessive use of alcohol or drugs (using ICD 10 RDC for alcohol or drug abuse or dependence) significant cognitive impairment (for example learning disability or dementia) and active psychosis.

Related studies

RECRUITINGPhase 1/2

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

NCT05685368 · Race-related Stress, Depression, Anxiety, and more

intErnet-based iNterventions FOR Cardiac arrEst suRvivors

NCT06395558 · Cognitive Impairment, Depression, Anxiety, and more

RECRUITINGPhase 2

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more

Training in Evidence-based Treatments in Psycho-Oncology

NCT05674357 · Distress, Emotional, Depression, Anxiety, and more

Promoting Mental Health of Teachers and Caregiver Using a Personalized mHealth Toolkit in Uganda

NCT06087159 · Mental Health Literacy, Depression, Anxiety

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 16, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment40

Start dateJan 2016

Last updatedAug 16, 2016

Condition

Depression, Anxiety

Locations shown

PRIME Foundation/ Lady Reading Hospital

Peshawar, Khyber Pakhtunkhwa

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 16, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions